Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders
All the news from Servier
Servier joins the United Nations Global Compact: A milestone for our sustainability commitment
Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business
Patient Voices: “The woman I got back after the operation was not the same”
Servier Ventures selects Cytospire Therapeutics for its first investment
#BecauseISaySo: An international campaign to keep blood pressure under control
Patient Voices: “We were very lucky!”
Servier completes the acquisition of Day One Biopharmaceuticals
Servier x L’ADN: The patient as a partner, a new figure in care